Technetium Tc 99m trofolastat

N/A

Report date: 2025/11/19 17:58:09
NME

Base Information

Drug NameTechnetium Tc 99m trofolastat
Drug Alias Name[99mTc]MIP-1404MIP-99mTc-1404PSMA-targeted imaging agent 140499mTc-trofolastatMIP-Tc-1404 +[11] 
ClassificationDiagnostic agent (In vivo) > Contrast agentRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Technetium > 99mTc +[5] 
Mechanisms of ActionDiagnostic imaging enhancersProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[9] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProgenics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMolecular Insight Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A